Economic Impact of Pharmaceutical Recommendations Carried Out in a Liver Transplant Unit of a University Hospital
Keywords:
Pharmaceutical Recommendation, Transplant, Clinical PharmacyAbstract
Introduction: Advances in medicine have provided the possibility of organs and tissues transplantation for therapeutic purposes. Transplant patients, in addition to immunosuppressive therapy, mostly undergo treatment for other comorbidities, and this polypharmacy makes the role of the pharmacist extremely important to ensure patient safety and adherence. Through pharmaceutical recommendations, the professional can reduce morbidity and mortality and thus reduce healthcare costs. Methods: This is an observational, retrospective descriptive study, carried out from January 2021 to December 2022, aiming to analyze the economic impact of pharmaceutical recommendations made in a liver transplant unit of an university hospital. Data collection took place from May to August 2023 through the institution’s clinical pharmacy database. The economic impact was classified as effectiveness increased (EI), cost reduction (RC), and avoided risk (AR) calculated through a methodology developed and adapted to the study’s reality. Medication acquisition costs were verified through the hospital’s own system, and the values were adjusted according to inflation in June 2023. Results: A total of 363 pharmaceutical recommendations (PR) were conducted, of which the EI represented 64% (n = 231), followed by RC (20%, n = 72) and risk avoided (16%, n = 60). The total resulting value corrected by the Índice Nacional de Preços ao Consumidor Amplo (IPCA) was R$ 179,223.31, with the AE at R$ 140,414.04 and the RC at R$ 38,809.27. Conclusion: The importance of the clinical pharmacist in the multidisciplinary team is evident through the improvement of patient monitoring and health condition management. Through this study, we can perceive that the PR presented had a considerable financial impact, and, through the optimization of pharmacotherapy for transplant patients, an increase in therapeutic EI was obtained. The importance of developing further studies showing the impact of the quality of care provided by the pharmacy’s performance is clear, to further highlight the importance of this field for healthcare assistance.
Downloads
References
Garcia CCM, Morbeck CAE, Batista CB. Percepção do estudante da faculdade de medicina sobre doação e transplante de órgãos e tecidos. Braz J Transplant 2022;25(4):e0622. https://doi.org/10.53855/bjt.v25i4.472_PT
Pacheco L. Transplante de fígado no Brasil. Rev Col Bras Cir 2016;43(4):223-4. https://doi.org/10.1590/0100-69912016004014
Oliveira PC, Paglione HB, Silva VS, Schirmer J, Bartira AR. Mensuração da não-adesão aos medicamentos imunossupressores em receptores de transplante de fígado. Acta Paul Enferm 2019;32(3):319-26. https://doi.org/10.1590/1982-0194201900044
Martins BCC, Souza TR, Luna AMPT, Fonteles MFF, Firmino PYM, Fernandes PFCBC, et al. Pharmaceutical care in transplant patients in a university hospital: pharmaceutical interventions. Braz J Pharm Sci 2013;49(4):659-68. https://doi.org/10.1590/S1984-82502013000400005
Schroeter G, Trombetta T, Faggiani FT, Goulart PV, Creutzberg M, Viegas K, et al. Terapia anti-hipertensiva utilizada por pacientes idosos de Porto Alegre/RS, Brasil. Sci Med 2007;17(1):14-9.
Mesquita MCO. Transplante hepático pediátrico: experiência do Hospital das Clínicas da UFMG. Belo Horizonte. Thesis [Master in Healthy Science] – Universidade Federal de Minas Gerais; 2007.
Hernanz BC. Detección de resultados negativos asociados a la medicación de pacientes de la unidad de observación del área de urgencias. Granada. Thesis [PhD in Phamacy] – Universidade de Granada; 2007.
Santos LRSS. Assistência e atenção farmacêutica: os desafios encontrados pelo profissional farmacêutico que atua em drogarias e farmácias de Porto Alegre, RS: um relato de experiência. Research Society Dev 2022;11(13):e245111334544. https://doi.org/10.33448/rsd-v11i13.34544
Cavalcante MG, Arruda KCO, Sousa MAL, Francelino EV. A importância da integração do farmacêutico clínico em uma unidade de terapia intensiva (UTI): uma revisão integrativa. Rev Expr Catól Saúde 2022;7(1):37-46. https://doi.org/10.25191/recs.v7i1.17
European Burns Association. European practice guidelines for burn care. Minimum level of burn care provision in Europe. 2017 [accessed on 05 Jan 2024]. Available at: https://www.euroburn.org/wp-content/uploads/EBA-Guidelines-Version-4-2017.pdf
Arantes T, Durval CC, Pinto VB. Avaliação da economia gerada por meio das intervenções farmacêuticas realizadas em um hospital universitário terciário de grande porte. Clin Biomed Res 2020;40(2):96-104. https://doi.org/10.22491/2357-9730.95646
Organização Pan-Americana da Saúde. Proposta. Consenso brasileiro de atenção farmacêutica. 2002 [accessed on 05 Jan 2024]. Available at: http://bvsms.saude.gov.br/bvs/publicacoes/PropostaConsensoAtenfar.pdf
Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist contributions as members of the multidisciplinary ICU team. Chest 2013;144(5):1687-95. https://doi.org/10.1378/chest.12-1615
Manias E, Kinney S, Cranswick N, Williams A, Borrott N. Interventions to reduce medication errors in pediatric intensive care. Ann Pharmacother 2014;48(10):1313-31. https://doi.org/10.1177/1060028014543795
Marconi MA, Lakatos EM. Metodologia do trabalho científico. São Paulo: Atlas; 2003.
Nesbit TW, Shermock KM, Bobek MB, Capozzi DL, Flores PA, Leonard MC, et al. Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. Am J Health Syst Pharm 2001;58(9):784-90. https://doi.org/10.1093/ajhp/58.9.784
Saokaew S, Maphanta S, Thangsomboon P. Impact of pharmacist’s interventions on cost of drug therapy in intensive care unit. Pharm Pract (Granada) 2009;7(2):81-7. https://10.4321/s1886-36552009000200003
Gallagher J, Byrne S, Woods N, Lynch D, McCarthy S. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital. BMC Health Serv Res 2014;14:177. https://doi.org/10.1186/1472-6963-14-177
Holanda ANM. Análise clínica e econômica das recomendações farmacêuticas em unidade de terapia intensiva. Fortaleza. Thesis [Master in Pharmaceutical Science] – Universidade Federal do Ceará; 2019.
Porto S, Martins M, Mendes W, Travassos C. A magnitude financeira dos eventos adversos em hospitais no Brasil. Rev Port Saúde Pública 2010;Vol Temat(10):74-80.
Brasil. Banco Central do Brasil. Calculadora do cidadão: correção de valores. 2023 [accessed on 10 Ago 2023]. Available at:: https://www3.bcb.gov.br/CALCIDADAO/publico/exibirFormCorrecaoValores.do?method=exibirFormCorrecaoValores
Rovers JP. Guia prático da atenção farmacêutica. São Paulo: Pharmabooks; 2010.
Aguiar MIF, Braga VAB, Garcia JHP, Lima CA, Almeida PC, Souza AMA, et al. Qualidade de vida em receptores de transplante de fígado e a influência dos fatores sociodemográficos. Rev Esc Enferm USP 2016;50(3):411-8. https://doi.org/10.1590/S0080-623420160000400006
Souza TR, Lopes DMA, Freire NM, Salmito GA, Vasconcelos HCA, Oliveira AB, et al. Importância do farmacêutico residente em uma unidade de transplante hepático e renal: intervenções farmacêuticas realizadas. Braz J Transplant 2010;13(2):1368-73. https://doi.org/10.53855/bjt.v13i2.239
Oliveira FRP, Magalhães VP, Cavalcante RMA, Guedes MM, Fonteles MMF, Silva LJ, et al. Acompanhamento farmacoterapêutico em unidade de internação pós-transplante: descrição e análise. Rev Eletr Farm 2019;16(E). https://doi.org/10.5216/ref.v16i0.45958
Pinheiro MK, Chaves EF, Oliveira AB, Andrade CC, Bastos KX, Guedes MM. Pharmaceutical recommendations in a university hospital transplant unit. Rev Bras Farm Hosp Serv Saúde 2019;10(4):361. https://doi.org/10.30968/rbfhss.2019.104.0361
Zanetti MOB. Impacto da inserção do farmacêutico clínico na equipe de transplante alogênico de células-tronco hematopoiéticas. Ribeirão Preto. Thesis [PhD in Pharmaceutical Sciences] – Universidade de São Paulo; 2020.
Martins BCC. Acompanhamento farmacoterapêutico de pacientes transplantados renais: da descrição aos desfechos clínicos. Fortaleza.Thesis [Master in Pharmaceutical Sciences] – Universidade Federal do Ceará; 2015.
Adriano LS, Martins BCC, Lima LF, Cavalcante RMDA, Oliveira FRPD, Magalhães VP, et al. Pharmaceutical interventions and their clinical outcomes in an inpatient post-transplant unit. Rev Bras Farm Hosp Serv Saúde 2017; 8(1):15-21. Available at: https://www.rbfhss.org.br/sbrafh/article/view/284
Rijdt TD, Ludo W, Steven S. Economic effects of clinical pharmacy interventions: s literature review. American J Health-System Pharm 2008;65(12):1161-72. https://doi.org/10.2146/ajhp070506
Nascimento LC. Custos decorrentes de eventos adversos a medicamentos em pacientes hospitalizados. Goiânia. Thesis [Master in Health Assistance and Assessment] – Universidade Federal de Goiás, 2018.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Lara Nascimento, Alene Barros de Oliveira, José Martins de Alcântara Neto, Maria Gabrielle oliveira e Silva Linhares, Cinthya Cavalcante de Andrade
This work is licensed under a Creative Commons Attribution 4.0 International License.
